𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term Results of Hyperfractionated Radiation Therapy and Concomitant Chemotherapy for T3 and T4 Nasopharyngeal Carcinoma

✍ Scribed by Tsai, Y.; Cheng, S.; Jian, J.; Chen, H.; Chu, N.; Chan, K.; Lin, C.; Terng, S.; Hong, C.

Book ID
123075647
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
38 KB
Volume
81
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neoadjuvant chemotherapy followed by con
Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3–T4) oropharyngeal squamous cell carcinoma
✍ Veronica Finnegan; James T. Parsons; Bruce D. Greene; Vinay Sharma πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 1 views

## Abstract ## Background Radiation therapy (RT) is commonly used in the management of patients with advanced (T3–T4) oropharyngeal squamous cell carcinomas. In recent years, based upon the meta‐analyses of randomized trials, chemotherapy administered concurrently with RT (chemoradiotherapy) has b

Induction chemotherapy and radiation the
Induction chemotherapy and radiation therapy for T4 oropharyngeal carcinoma
✍ Rakesh M. Nathu; William M. Mendenhall; James T. Parsons; Anthony A. Mancuso; Ro πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 132 KB πŸ‘ 2 views

Between 1964 and 1996, 123 patients were treated for T4 oropharyngeal carcinoma; 93 were treated with radiation therapy alone; 30 were treated with induction chemotherapy and radiation therapy. Patients who received induction chemotherapy and radiation therapy were treated between 1985 and 1996; dur

Long-term results of hyperfractionated r
Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma
✍ Paul M. Spring; Joseph Valentino; Susanne M. Arnold; David Sloan; Daniel Kenady; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 123 KB

## Abstract ## BACKGROUND In this report, the authors present the results from a study of patients with unresectable oropharyngeal squamous cell carcinomas who were treated on a protocol of hyperfractionated radiation and high‐dose intraarterial cisplatin (HYPERRADPLAT) at the University of Kentuc